Skip to content

Amrize

US · AMRZ #911 by market cap Listed 2025
36.39 -0.89 -2.39%
Live - 5344 symbols - heartbeat 268s ago · 2026-10-08 07:35
Pre-market 35.93 -1.26%
After-hours 36.39 0.00%
Overnight 35.90 -1.35%
Market cap
19.90B
P/B
1.55
EPS
2.14
Reader sentiment Are you bullish or bearish on AMRZ?

Anonymous reader poll. Unscientific, not investment advice.

Shares of Amrize closed at 36.39, down 2.39%. The company carries a market value of roughly 19.90B, the #911 most valuable US-listed company we track. Valuation-wise, the P/E sits at 16.65, 31% below the five-year average of 24.03. The 11 analysts covering the stock are, on balance, at Buy, targeting an average of 51.44 (+41%). Against a 52-week band of 36.17-65.13, the shares are currently 1% of the way up.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -25.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 1.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 7 days E → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 977 U.S. stocks StockVane covers.

Overall C
ValuationGrowthProfitMomentumHealthAnalyst
Valuation A-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 16.6x Better than 59%
Forward P/E 14.7x Better than 61%
Price / Sales 1.7x Better than 69%
P/E vs own 5-yr range 1st pctl Better than 95%
Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 3.3% Better than 34%
Net income CAGR (3Y) 2.3% Better than 43%
Free cash flow CAGR (3Y) -1.8% Better than 31%
Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 25.7% Better than 22%
Operating margin 16.1% Better than 53%
Net margin 10.0% Better than 46%
Return on equity 8.9% Better than 33%
Return on invested capital 7.8% Better than 44%
Momentum D-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -26.8% Better than 5%
6-month return -30.0% Better than 4%
12-month return (ex latest month) -8.2% Better than 22%
Distance below 52-week high 42.9% Better than 12%
Financial Health B-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.6x Better than 57%
Debt to assets 26.2% Better than 56%
Interest coverage 4.6x Better than 39%
Free cash flow / net income 119.8% Better than 56%
Analyst View C+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 36.4% Better than 17%
Upside to average target 38.3% Better than 72%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.

Price chart

59.2336.3936.392026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W -2.67%
1M -16.96%
3M -28.39%
6M -31.57%
YTD -31.89%
1Y -21.84%

Key statistics

Price & volume

Prev close
37.28
Open
36.95
Day range
36.17 - 37.09
Avg price
36.41
Volume
4.25M
Turnover
154.61M
Amplitude
2.47%
52-week range
36.17 - 65.13

Valuation

P/E
16.98
P/E (TTM)
16.20
P/B
1.55
EPS
2.14
Net profit
1.17B
Net assets
12.87B

Share structure

Market cap
19.90B
Float cap
17.94B
Shares out
546.93M
Float shares
493.06M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2025-06-23
52-week range 1% of range
36.17 65.13

44.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-100.18M net over the window

Short interest

Shares short
9.74M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Amrize (AMRZ)?

Amrize last traded at 36.39. The quote on this page refreshes every few seconds while US markets are open.

What is Amrize's market cap?

About 19.90B.

What is the P/E ratio of Amrize?

The trailing twelve-month P/E is 16.20, below its own 5-year average of 24.03 — toward the bottom of its historical range (0.93% percentile). See the Valuation tab for the full history.

Does Amrize pay a dividend?

Amrize does not currently pay a regular dividend.

Is Amrize a buy according to analysts?

The consensus of 11 analysts is a Buy rating, with an average 12-month price target of 51.44, which implies 41.4% upside from the current price. This is not investment advice.

What is Amrize's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Amrize a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-10-08 07:35:41 · For reference only, not investment advice and not tailored to your situation.